ArticleVirology journal2025
Circadian clock proteins BMAL1 and CLOCK regulate HSV-1 entry into nerve cells through NECTIN-1.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Circadian-guided oncolytic virotherapy for glioblastoma.Journal of neurovirology · 2026Review
- The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHerpes simplex virus type 1 (HSV-1) is a double-stranded DNA virus that establishes lifelong latency and can cause fatal herpes encephalitis. This study aimed to identify key clock genes regulating HSV-1 infection and to elucidate the underlying mechanisms.
methodsTranscriptomic analyses of the brainstem and hippocampus in mice were conducted to identify clock genes potentially involved in HSV-1 regulation. A serum shock cell model was employed to assess the impact of temporal variations in NECTIN-1 expression on HSV-1 infection. Luciferase reporter assays and chromatin immunoprecipitation (ChIP) were used to investigate the transcriptional regulatory mechanisms.
resultsNECTIN-1, a primary receptor mediating HSV-1 entry into neurons, exhibited rhythmic expression in both the brainstem and hippocampus of mice. In vitro assays further demonstrated that HSV-1 DNA copy numbers fluctuated in near synchrony with NECTIN-1 expression levels. Overexpression of the core clock factors BMAL1 and CLOCK significantly increased NECTIN-1 expression. Mechanistically, BMAL1 and CLOCK bind directly to E-box-like motifs in the NECTIN-1 promoter region, thereby enhancing its transcriptional activity. Furthermore, pharmacological inhibition of CLOCK using CLK8 markedly suppressed HSV-1 infection.
conclusionsTogether, our findings reveal a novel mechanism by which the circadian clock modulates HSV-1 entry through rhythmic regulation of the NECTIN-1 receptor. BMAL1 and CLOCK emerge as potential therapeutic targets for circadian-based antiviral strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.